Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]A Review of its Use as an Active Immunization Against Influenza A Subtype H5N1 Virus

被引：0
|
作者：
Natalie J. Carter
Greg L. Plosker
机构：
[1] Wolters Kluwer Health ¦ Adis,
[2] Wolters Kluwer Health,undefined
来源：
BioDrugs | 2008年 / 22卷
关键词：
Influenza; Influenza Vaccine; Vaccine Strain; Seasonal Influenza; Influenza Pandemic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：279 / 292
页数：13
相关论文
共 50 条
  • [21] Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)
    Harvey, Ruth
    Wheeler, Jun X.
    Wallis, Chantal L.
    Robertson, James S.
    Engelhardt, Othmar G.
    VACCINE, 2008, 26 (51) : 6550 - 6554
  • [22] Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I-II randomized trial
    Wu, Jiang
    Liu, Shu-Zhen
    Dong, Shan-Shan
    Dong, Xiao-Ping
    Zhang, Wu-Li
    Lu, Min
    Li, Chang-Gui
    Zhou, Ji-Chen
    Fang, Han-Hua
    Liu, Yan
    Liu, Li-Ying
    Qiu, Yuan-Zheng
    Gao, Qiang
    Zhang, Xiao-Mei
    Chen, Jiang-Ting
    Zhong, Xiang
    Yin, Wei-Dong
    Feng, Zi-Jian
    VACCINE, 2010, 28 (38) : 6221 - 6227
  • [23] Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice
    Nakatsukasa, Akihiro
    Kuruma, Koji
    Okamatsu, Masatoshi
    Hiono, Takahiro
    Suzuki, Mizuho
    Matsuno, Keita
    Kida, Hiroshi
    Oyamada, Takayoshi
    Sakoda, Yoshihiro
    VACCINE, 2017, 35 (21) : 2855 - 2861
  • [24] Effect of Influenza A(H5N1) Vaccine Prepandemic Priming on CD4+ T-Cell Responses
    Nayak, Jennifer L.
    Richards, Katherine A.
    Yang, Hongmei
    Treanor, John J.
    Sant, Andrea J.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (09) : 1408 - 1417
  • [25] Prediction of mutations in H5N1 hemagglutinins from influenza A virus
    Wu, Guang
    Yan, Shaomin
    PROTEIN AND PEPTIDE LETTERS, 2006, 13 (10) : 971 - 976
  • [26] Pandemics, avian influenza A (H5N1), and a strategy for pharmacists
    Ford, SM
    Grabenstein, JD
    PHARMACOTHERAPY, 2006, 26 (03): : 312 - 322
  • [27] Are we ready for pandemic influenza H5N1?
    Stephenson, I
    EXPERT REVIEW OF VACCINES, 2005, 4 (02) : 151 - 155
  • [28] Evolution of an avian H5N1 influenza A virus escape mutant
    Kamel M A Hassanin
    Ahmed S Abdel-Moneim
    World Journal of Virology, 2013, (04) : 160 - 169
  • [29] Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines
    Thueng-in, Kanyarat
    Maneewatch, Santi
    Srimanote, Potjanee
    Songserm, Thaweesak
    Tapchaisri, Pramuan
    Sookrung, Nitat
    Tongtawe, Pongsri
    Channarong, Sunee
    Chaicumpa, Wanpen
    VACCINE, 2010, 28 (41) : 6765 - 6777
  • [30] Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine
    Geeraedts, Felix
    ter Veer, Wouter
    Wilschut, Jan
    Huckriede, Anke
    de Haan, Aalzen
    VACCINE, 2012, 30 (45) : 6501 - 6507
12345